sellWeak cluster of 310b5-1 plan
Douglas Evan Godshall sold $2.2M of SWAV
President & CEO at Shockwave Medical, Inc.. 10,000 shares at an average of $217.59, traded Jan 16, 2024, filed Jan 18, 2024.
Warning score
30Value
$2.2M
10,000 shares
Holdings after
141,057
-7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +25Trade size$2.2M at market
- 0Share of holdings soldSold 6.6% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001642545-24-000012, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 16, 2024 | MOption exercise Common Stock10b5-1 | +10,000 | $3.42 | $34k | 151,057 | Jan 18, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -300 | $215.54 | $65k | 150,757 | Jan 18, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -6,150 | $216.87 | $1.3M | 144,607 | Jan 18, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -1,302 | $217.97 | $284k | 143,305 | Jan 18, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -1,248 | $219.27 | $274k | 142,057 | Jan 18, 2024 |
| Jan 16, 2024 | SOpen-market sale Common Stock10b5-1 | -1,000 | $220.00 | $220k | 141,057 | Jan 18, 2024 |
| Jan 17, 2024 | AGrant or award Common Stock10b5-1 | +22,078 | $0.00 | $0 | 163,135 | Jan 18, 2024 |
| Jan 18, 2024 | FTax withholding Common Stock10b5-1 | -10,250 | $217.78 | $2.2M | 152,885 | Jan 18, 2024 |
| Jan 16, 2024 | MOption exercise Stock Optionderivative10b5-1 | -10,000 | $0.00 | $0 | 304,799 | Jan 18, 2024 |
Related signals
Other insiders at Shockwave Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Shockwave Medical, Inc. | Laura Francis director | $450k 1,500 shares | -30% | |
| 33Weak | Shockwave Medical, Inc. | Isaac Zacharias President, CCO | $1.2M 4,000 shares | -7% | |
| 23Weak | Shockwave Medical, Inc. | Frank T Watkins director | $507k 2,000 shares | -31% | |
| 10Weak | Shockwave Medical, Inc. | Trinh Phung VP, Finance | $5,316 21 shares | -0% | |
| 40Moderate | Shockwave Medical, Inc. | Isaac Zacharias President, CCO | $1.0M 4,000 shares | -6% | |
| 60Notable | Shockwave Medical, Inc. | Frederic H Moll director | $15M 60,000 shares | -17% | |
| 21Weak | Shockwave Medical, Inc. | Trinh Phung VP, Finance | $155k 599 shares | -2% | |
| 13Weak | Shockwave Medical, Inc. | Laura Francis director | $250k 1,000 shares | -22% | |
| 30Weak | Shockwave Medical, Inc. | Douglas Evan Godshall President & CEO | $2.3M 10,000 shares | -6% | |
| 24Weak | Shockwave Medical, Inc. | Trinh Phung VP, Finance | $299k 1,287 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.